000 01263 a2200349 4500
005 20250513093225.0
264 0 _c19960910
008 199609s 0 0 eng d
022 _a0009-9104
024 7 _a10.1046/j.1365-2249.1996.d01-773.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDe Wit, D
245 0 0 _aIL-12 stimulation but not B7 expression increases melanoma killing by patient cytotoxic T lymphocytes (CTL).
_h[electronic resource]
260 _bClinical and experimental immunology
_cAug 1996
300 _a353-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aB7-1 Antigen
_xphysiology
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aHumans
650 0 4 _aInterleukin-12
_xpharmacology
650 0 4 _aMelanoma
_ximmunology
650 0 4 _aT-Lymphocytes, Cytotoxic
_ximmunology
650 0 4 _aTumor Cells, Cultured
700 1 _aFlemming, C L
700 1 _aHarris, J D
700 1 _aPalmer, K J
700 1 _aMoore, J S
700 1 _aGore, M E
700 1 _aCollins, M K
773 0 _tClinical and experimental immunology
_gvol. 105
_gno. 2
_gp. 353-9
856 4 0 _uhttps://doi.org/10.1046/j.1365-2249.1996.d01-773.x
_zAvailable from publisher's website
999 _c8703588
_d8703588